Categories: News

DeTect and Hanseo University Deepen Collaboration with Radar Deployment at the Taean Flight Education Center

TAEAN, South Korea, July 2, 2025 /PRNewswire/ — DeTect, Inc., a global leader in advanced radar and remote sensing technologies, is expanding its strategic collaboration with Hanseo University through the deployment of DeTect’s MERLIN™ True3D™ Aircraft Birdstrike Avoidance Radar and a MERLIN™ 7360 True3D radar system at Hanseo’s Taean campus. This marks a significant milestone in the evolving relationship between the two organizations and underscores their shared commitment to advancing aviation safety and radar research in South Korea.

- Advertisement -

The partnership is deeply rooted in the relationship between the two founders – Dr. Ham Ki-sun, President and Founder of Hanseo University, and Gary W. Andrews, Co-Founder of DeTect, Inc. Their rapport and mutual respect have evolved into an alliance grounded in shared values: innovation, education, public safety and environmental protection. Both leaders continue to guide their organizations with a long-term perspective, and the current collaboration reflects that vision.

- Advertisement -

As part of an ongoing partnership, DeTect’s radar has been installed at Hanseo University’s Taean campus, supported by DeTect Korea staff. DeTect’s mostly widely deployed Bird Detection Radar in the world—trusted by NASA and airports globally—it provides real-time avian tracking and automated alerts to help prevent bird strikes.

- Advertisement -

This unit will play a critical role in developing and testing bird strike prevention strategies for Korean airports, where bird strikes are a growing concern. By simulating real-world conditions and analyzing regional bird migration, researchers will generate data-driven insights for aviation stakeholders. DeTect’s radar will serve as a national reference for evaluating radar-based aviation safety and environmental monitoring technologies.

- Advertisement -

“We are proud to work with a forward-thinking institution like Hanseo University,” said Gary W. Andrews, DeTect President and CEO. “Together, we are laying the foundation for impactful research, enhanced aviation safety, and lasting innovation in Korea.” The deployment brings world-class radar capabilities to the region and positions the university as a national leader in radar technology.

- Advertisement -

 

- Advertisement -

 

- Advertisement -

Photo – https://mma.prnewswire.com/media/2722780/DeTect_Hanseo_University_Library.jpg

- Advertisement -

Photo – https://mma.prnewswire.com/media/2722781/Hanseo_University_DeTect_Aircraft_Radar.jpg

- Advertisement -

Photo – https://mma.prnewswire.com/media/2722782/DeTect_Korean_Office.jpg

- Advertisement -

Logo – https://mma.prnewswire.com/media/2606895/DeTect_Logo___Intelligent_Sensors_Black_NO_TM_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/detect-and-hanseo-university-deepen-collaboration-with-radar-deployment-at-the-taean-flight-education-center-302496679.html

- Advertisement -

Recent Posts

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026…

2 hours ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI,…

2 hours ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing…

2 hours ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies

AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of the AlUla Conference…

2 hours ago

Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…

2 hours ago

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

February 06, 2026 17:17 ET  | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06,…

2 hours ago